Anaplastic lymphoma kinase (ALK) gene rearrangements are a rare and unique molecular subset of non-small cell lung cancer (NSCLC), present in approximately 5% of cases overall, most with adenocarcinoma histology. This evidence concerns the gene ALK and adenocarcinoma.